B-hHLA-DRB1*1.1 mice

C57BL/6-H2-Eatm1(HLA-DRA1*1.1-I-Ea)Bcgen H2-Eb1tm1(HLA-DRB1*1.1-I-Eb1)Bcgen H2-Atm1Bcgen H2-Eb2tm1Bcgen/Bcgen • 112898

商品を注文する

B-hHLA-DRB1*1.1 mice

Product nameB-hHLA-DRB1*1.1 mice
Catalog number112898
Strain nameC57BL/6-H2-Eatm1(HLA-DRA1*1.1-I-Ea)Bcgen H2-Eb1tm1(HLA-DRB1*1.1-I-Eb1)Bcgen H2-Atm1Bcgen H2-Eb2tm1Bcgen/Bcgen
Strain backgroundC57BL/6
NCBI gene ID3122,3123 (Human)
AliasesHLA-DRA1; SS1, DRB1, HLA-DRB, HLA-DR1B
商品を注文する

このページで

  • Description
  • Targeting strategy
  • Phenotypic analysis

ポスター

すべて表示

    出版物

      関連商品

      すべて表示
      Description
      • HLA-DRA is one of the HLA class II alpha chain paralogues. HLA-DRB1 belongs to the HLA class II beta chain paralogs. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5.
      • The exon 2 of mouse I-Ea gene that encodes the extracellular domain of I-Ea was replaced by human HLA-DRA encoding the α1 domain in B-hHLA-DRB1*1.1 mice. The exon 2 of mouse I-Eb1 gene that encodes the extracellular domain of I-Eb1 was replaced by human HLA-DRB encoding the β1 domain in B-hHLA-DRB1*1.1 mice. The  mouse I-Aa, I-Ab1 and I-Eb2 were knocked out in B-hHLA-DRB1*1.1 mice.
      • Human HLA-DRB1 was exclusively detectable in homozygous B-hHLA-DRB1*1.1 mice, but not in wild-type C57BL/6JNifdc mice.
      • B-hHLA-DRB1*1.1 mice provide a powerful preclinical model for in vivo evaluation of vaccines.
      • Application: For example, this product is used for pharmacodynamics and safety evaluation of vaccines for cancers.
      Targeting Strategy

      Gene targeting strategy for B-hHLA-DRB1*1.1 mice. The exon 2 of mouse I-Ea gene that encodes the extracellular domain of I-Ea was replaced by human HLA-DRA encoding the α1 domain in B-hHLA-DRB1*1.1 mice. The exon 2 of mouse I-Eb1 gene that encodes the extracellular domain of I-Eb1 was replaced by human HLA-DRB encoding the β1 domain in B-hHLA-DRB1*1.1 mice. The  mouse I-Aa, I-Ab1 and I-Eb2 were knocked out in B-hHLA-DRB1*1.1 mice.

      Protein Expression Analysis in Spleen

      Strain specific HLA-DRB1 expression analysis in wild-type C57BL/6JNifdc mice and homozygous B-hHLA-DRB1*1.1 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc (+/+) and homozygous humanized B-hHLA-DRB1*1.1 mice (H/H), respectively, and analyzed by flow cytometry with species-specific anti-mouse I-A/I-E antibody (Biolegend, 107607), and species-specific anti-human HLA-DR antibody (Biolegend, 307610). Human HLA-DRB1 was exclusively detectable in homozygous B-hHLA-DRB1*1.1 mice, but not in wild-type C57BL/6JNifdc mice.

      Protein Expression Analysis in Blood

      Strain specific HLA-DRB1 expression analysis in wild-type C57BL/6JNifdc mice and homozygous B-hHLA-DRB1*1.1 mice by flow cytometry. Blood cells were collected from wild-type C57BL/6JNifdc mice (+/+) and homozygous humanized B-hHLA-DRB1*1.1 mice (H/H), respectively, and analyzed by flow cytometry with species-specific anti-mouse I-A/I-E antibody (Biolegend, 107607), and species-specific anti-human HLA-DR antibody (Biolegend, 307610). Human HLA-DRB1 was exclusively detectable in homozygous B-hHLA-DRB1*1.1 mice, but not in wild-type C57BL/6JNifdc mice.

      Protein Expression Analysis in Bone Marrow

      Strain specific HLA-DRB1 expression analysis in wild-type C57BL/6JNifdc mice and homozygous B-hHLA-DRB1*1.1 mice by flow cytometry. Bone marrow cells were collected from wild-type C57BL/6JNifdc mice (+/+) and homozygous humanized B-hHLA-DRB1*1.1 mice (H/H), respectively, and analyzed by flow cytometry with species-specific anti-mouse I-A/I-E antibody (Biolegend, 107607), and species-specific anti-human HLA-DR antibody (Biolegend, 307610). Human HLA-DRB1 was exclusively detectable in homozygous B-hHLA-DRB1*1.1 mice, but not in wild-type C57BL/6JNifdc mice.

      Frequency of Leukocyte Subpopulations in Spleen

      Frequency of leukocyte subpopulations in spleen by flow cytometry. Splenocytes were isolated from wild-type C57BL/6JNifdc mice (female, n=3, 8-week-old) and homozygous B-hHLA-DRB1*1.1 mice (female, n=3, 8-week-old). A. Flow cytometry analysis of the splenocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Frequencies of T cells, B cells, NK cells, dendritic cells, neutrophils, monocytes, macrophages, and Tregs in B-hHLA-DRB1*1.1 mice were similar to those in C57BL/6JNifdc mice. Compared with C57BL/6JNifdc mice, the frequency of CD4+ T cells in B-hHLA-DRB1*1.1 mice was increased than C57BL/6JNifdc mice, while the frequency of CD8+ T cells in B-hHLA-DRB1*1.1 mice was decreased than C57BL/6JNifdc mice in the spleen. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test.  *P < 0.05, **P < 0.01, ***P < 0.001.

      Frequency of Leukocyte Subpopulations in Blood

      Frequency of leukocyte subpopulations in blood by flow cytometry. Blood cells were isolated from wild-type C57BL/6JNifdc mice (female, n=3, 8-week-old) and homozygous B-hHLA-DRB1*1.1 mice (female, n=3, 8-week-old). A. Flow cytometry analysis of the blood leukocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Frequencies of T cells, B cells, NK cells, dendritic cells, neutrophils, monocytes, macrophages, and Tregs in B-hHLA-DRB1*1.1 mice were similar to those in C57BL/6JNifdc mice. Compared with C57BL/6JNifdc mice, the frequency of CD4+ T cells in B-hHLA-DRB1*1.1 mice was increased than C57BL/6JNifdc mice. The frequency of CD8+ T cells in B-hHLA-DRB1*1.1 mice was decreased than C57BL/6JNifdc mice, but there was no statistical difference in the blood. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test.  *P < 0.05, **P < 0.01, ***P < 0.001.

      Frequency of Leukocyte Subpopulations in Lymph Node

      Frequency of leukocyte subpopulations in lymph node by flow cytometry. Lymph node cells were isolated from wild-type C57BL/6JNifdc mice (female, n=3, 8-week-old) and homozygous B-hHLA-DRB1*1.1 mice (female, n=3, 8-week-old). A. Flow cytometry analysis of the leukocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Frequencies of T cells, B cells, NK cells, dendritic cells, neutrophils, monocytes, macrophages, and Tregs in B-hHLA-DRB1*1.1 mice were similar to those in C57BL/6JNifdc mice. Compared with C57BL/6JNifdc mice, the frequency of CD4+ T cells in B-hHLA-DRB1*1.1 mice was increased than C57BL/6JNifdc mice, but there was no statistical difference. The frequency of CD8+ T cells in B-hHLA-DRB1*1.1 mice was decreased than C57BL/6JNifdc mice in the lymph node. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test.  *P < 0.05, **P < 0.01, ***P < 0.001.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hHLA-DRB1*1.1 mice] (Cat# 112898) was purchased from Biocytogen.